Your browser doesn't support javascript.
loading
Nonmedical costs associated with rotavirus disease requiring hospitalization.
Lee, Brian P; Azimi, Parvin H; Staat, Mary Allen; Louie, Leslie; Parada, Ester; Berke, Tamas; Ward, Richard L; Bernstein, David I; Matson, David O.
Afiliación
  • Lee BP; Children's Hospital and Research Center at Oakland, Oakland, CA, USA. blee@mail.cho.org
Pediatr Infect Dis J ; 24(11): 984-8, 2005 Nov.
Article en En | MEDLINE | ID: mdl-16282934
ABSTRACT

BACKGROUND:

As the most common cause of severe diarrhea among children, rotavirus has a significant economic impact. Previous studies focused on the direct medical costs of rotavirus infections; however, nonmedical costs account for the majority of the financial burden from this disease. Herein, we report the results from the largest prospective study in the United States determining the nonmedical costs of severe rotavirus infections.

METHODS:

Prospective, active, gastroenteritis case surveillance was conducted between November 1997 and December 1999 at 3 pediatric medical centers. Rotavirus infection was identified for 548 children admitted between 2 weeks and 5 years of age. Detailed information about nonmedical costs during the prehospitalization, hospitalization and posthospitalization periods was obtained through interviews.

RESULTS:

The average nonmedical cost per case of rotavirus disease was USD $448.77, including $359.04 for missed work, $56.66 for transportation, $11.90 for oral rehydration solutions, $9.59 for diapers, $6.83 for child care changes, $3.82 for special foods and $0.93 for formula changes. More than one-half of these expenses (53%) occurred outside the hospitalization period, and 80% of the cost was attributable to missed work.

CONCLUSIONS:

With an estimated 50,000 hospitalizations attributable to rotavirus each year in the United States, the nonmedical costs of severe rotavirus infections may exceed USD $22 million annually. Previous cost effectiveness analyses of rotavirus vaccines substantially underestimated this burden, suggesting that the nonmedical costs associated with mild to moderate rotavirus disease have been similarly underestimated. These findings are needed to assess accurately the cost effectiveness of future rotavirus immunization strategies.
Asunto(s)
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Infecciones por Rotavirus / Costo de Enfermedad / Vacunas contra Rotavirus / Gastroenteritis Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: America do norte Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Bases de datos: MEDLINE Asunto principal: Infecciones por Rotavirus / Costo de Enfermedad / Vacunas contra Rotavirus / Gastroenteritis Tipo de estudio: Health_economic_evaluation / Observational_studies / Prognostic_studies Límite: Child, preschool / Female / Humans / Infant / Male / Newborn País/Región como asunto: America do norte Idioma: En Revista: Pediatr Infect Dis J Asunto de la revista: DOENCAS TRANSMISSIVEIS / PEDIATRIA Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos